+91 8483 9659 21 (APAC)

+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)

sales@researchlayer.com
  1. Home
  2. Healthcare
  3. Global Gabapentin Market Research Rrport - Forecast Till 2032

Global Gabapentin Market Research Report: Information By Dosage Form (Tablet, Capsule, and Oral Solution), By Type (Generic and Branded), By Application (Epilepsy, Neuropathic Pain, Restless Legs Syndrome, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032.

  •  Region : Global
  • Healthcare
  • Published Report
  • Aug 2023
  •  Pages : 300
  •  Format : PDF/Excel
  •  Report ID : RL65112

Table of Contents

1.    Executive summary

2.    Market Introduction

2.1. Definition

2.2. Scope of the Study

2.2.1.  Research Objective

2.2.2.  Assumptions

2.2.3.  Limitations         

3.    Research Methodology

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1.         Primary Interviews and Information Gathering Process

3.4.2.         Breakdown of Primary Respondents  

3.5. Forecasting Modality

3.6. Market Size Estimation

3.6.1.         Bottom-Up Approach

3.6.2.         Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4.    Market Dynamics

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5.    Market Factor Analysis

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1.  Bargaining Power of Suppliers

5.2.2.  Bargaining Power of Buyers

5.2.3.  Threat of New Entrants

5.2.4.  Threat of Substitutes

5.2.5.  Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1.  Market Impact Analysis

5.3.2.  Regional Impact

5.3.3.  Opportunity and Threat Analysis

6.    GLOBAL Gabapentin MARKET, BY Dosage Form

6.1. Overview

6.2. Tablet

6.3. Capsule

6.4. Oral Solution

7.    GLOBAL Gabapentin MARKET, BY Type

7.1. Overview

7.2. Generic

7.3. Branded

8.    GLOBAL Gabapentin MARKET, BY Application

8.1. Overview

8.2. Epilepsy

8.3. Neuropathic Pain

8.4. Restless Legs Syndrome

8.5. Others

9.    GLOBAL Gabapentin MARKET, BY End-use

9.1. Overview

9.2. Hospital Pharmacy

9.3. Retail Pharmacy

9.4. Online Pharmacy

10. GLOBAL Gabapentin MARKET, by Region

10.1. Overview

10.2. North America

10.2.1.      U.S.

10.2.2.      Canada

10.3. Europe

10.3.1.      Germany

10.3.2.      France

10.3.3.      U.K

10.3.4.      Italy

10.3.5.      Spain

10.3.6.      Rest of Europe

10.4. Asia-Pacific

10.4.1.      China

10.4.2.      India

10.4.3.      Japan

10.4.4.      South Korea

10.4.5.      Australia

10.4.6.      Rest of Asia-Pacific

10.5. Rest of the World

10.5.1.      Middle East

10.5.2.      Africa

10.5.3.      Latin America

11. Competitive Landscape

11.1. Overview         

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Gabapentin Market,

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Global Gabapentin Market,

11.7. Key developments and Growth Strategies

11.7.1.                      New Dosage Form Launch/Type Application

11.7.2.                      Merger & Acquisitions

11.7.3.                      Joint Ventures

11.8. Major Players Financial Matrix

11.8.1.      Sales & Operating Income, 2022

11.8.2.      Major Players R&D Expenditure. 2022

12. Company ProfileS

12.1. ZYDUS PHARMACEUTICALS, INC

12.1.1.                      Company Overview

12.1.2.                      Financial Overview

12.1.3.                      Dosage Forms Offered

12.1.4.                      Key Developments

12.1.5.                      SWOT Analysis

12.1.6.                      Key Strategies

12.2. Glenmark Pharmaceuticals Limited

12.2.1.                      Company Overview

12.2.2.                      Financial Overview

12.2.3.                      Dosage Forms Offered

12.2.4.                      Key Developments

12.2.5.                      SWOT Analysis

12.2.6.                      Key Strategies

12.3. SUN PHARMACEUTICAL INDUSTRIES LTD.

12.3.1.                      Company Overview

12.3.2.                      Financial Overview

12.3.3.                      Dosage Forms Offered

12.3.4.                      Key Developments

12.3.5.                      SWOT Analysis

12.3.6.                      Key Strategies

12.4. Ascend Laboratories, LLC

12.4.1.                      Company Overview

12.4.2.                      Financial Overview

12.4.3.                      Dosage Forms Offered

12.4.4.                      Key Developments

12.4.5.                      SWOT Analysis

12.4.6.                      Key Strategies

12.5. Apotex Inc.

12.5.1.                      Company Overview

12.5.2.                      Financial Overview

12.5.3.                      Dosage Forms Offered

12.5.4.                      Key Developments

12.5.5.                      SWOT Analysis

12.5.6.                      Key Strategies

12.6. TEVA PHARMACEUTICAL INDUSTRIES LTD.

12.6.1.                      Company Overview

12.6.2.                      Financial Overview

12.6.3.                      Dosage Forms Offered

12.6.4.                      Key Developments

12.6.5.                      SWOT Analysis

12.6.6.                      Key Strategies

12.7. Aurobindo Pharma

12.7.1.                      Company Overview

12.7.2.                      Financial Overview

12.7.3.                      Dosage Forms Offered

12.7.4.                      Key Developments

12.7.5.                      SWOT Analysis

12.7.6.                      Key Strategies

12.8. Amneal Pharmaceuticals LLC.

12.8.1.                      Company Overview

12.8.2.                      Financial Overview

12.8.3.                      Dosage Forms Offered

12.8.4.                      Key Developments

12.8.5.                      SWOT Analysis

12.8.6.                      Key Strategies

12.9. Cipla USA, Inc.

12.9.1.                      Company Overview

12.9.2.                      Financial Overview

12.9.3.                      Dosage Forms Offered

12.9.4.                      Key Developments

12.9.5.                      SWOT Analysis

12.9.6.                      Key Strategies

13. Appendix

13.1. References

13.2. Related Reports

 

 

LIST OF TABLES

TABLE 1                 Global Gabapentin Market, Synopsis, 2018-2032

TABLE 2                 Global Gabapentin Market, Estimates & Forecast, 2018-2032 (USD BILLION)

TABLE 3                 GLOBAL Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 4                 GLOBAL Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 5                 GLOBAL Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 6                 GLOBAL Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 7                 North America Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 8                 North America Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 9                 North America Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 10             North America Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 11             North America Gabapentin MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 12             U.S. Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 13             U.S. Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 14             U.S. Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 15             U.S. Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 16             Canada Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 17             Canada Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 18             Canada Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 19             Canada Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 20             Europe Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 21             Europe Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 22             Europe Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 23             Europe Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 24             Europe Gabapentin MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 25             Germany Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 26             Germany Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 27             Germany Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 28             Germany Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 29             France Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 30             France Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 31             France Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 32             France Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 33             Italy Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 34             Italy Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 35             Italy Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 36             Italy Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 37             Spain Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 38             Spain Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 39             Spain Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 40             Spain Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 41             U.K Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 42             U.K Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 43             U.K Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 44             U.K Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 45             Rest of Europe Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 46             Rest of Europe Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 47             Rest of Europe Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 48             Rest of Europe Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 49             Asia Pacific Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 50             Asia Pacific Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 51             Asia Pacific Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 52             Asia Pacific Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 53             Asia Pacific Gabapentin MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 54             Japan Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 55             Japan Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 56             Japan Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 57             Japan Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 58             China Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 59             China Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 60             China Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 61             China Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 62             India Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 63             India Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 64             India Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 65             India Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 66             Australia Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 67             Australia Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 68             Australia Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 69             Australia Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 70             south korea Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 71             south korea Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 72             south korea Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 73             south korea Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 74             Rest of asia-pacific Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 75             Rest of asia-pacific Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 76             Rest of asia-pacific Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 77             Rest of asia-pacific Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 78             Rest of WOrld Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 79             Rest of WOrld Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 80             Rest of WOrld Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 81             Rest of WOrld Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 82             Rest of WOrld Gabapentin MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 83             Middle east Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 84             Middle east Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 85             Middle east Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 86             Middle east Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 87             Africa Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 88             Africa Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 89             Africa Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 90             Africa Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 91             Latin america Gabapentin MARKET, BY Dosage Form, 2018-2032 (USD BILLION)

TABLE 92             Latin america Gabapentin MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 93             Latin america Gabapentin MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 94             Latin america Gabapentin MARKET, BY END-USE, 2018-2032 (USD BILLION)

 

LIST OF FIGURES

FIGURE 1             Research Process

FIGURE 2             Market Structure for the Global Gabapentin Market

FIGURE 3             Market Dynamics for the Global Gabapentin Market

FIGURE 4             Global Gabapentin Market, Share (%), BY Dosage Form, 2022

FIGURE 5             Global Gabapentin Market, Share (%), BY TYPE, 2022

FIGURE 6             Global Gabapentin Market, Share (%), BY APPLICATION, 2022

FIGURE 7             Global Gabapentin Market, Share (%), BY END-USE, 2022

FIGURE 8             Global Gabapentin Market, Share  (%), by Region, 2022

FIGURE 9             north AMERICA: Gabapentin MARKET, SHARE (%), BY REGION, 2022

FIGURE 10         Europe: Gabapentin MARKET, SHARE (%), BY REGION, 2022

FIGURE 11         Asia-Pacific: Gabapentin MARKET, SHARE  (%), BY REGION, 2022

FIGURE 12         Rest of the world: Gabapentin MARKET, SHARE (%), BY REGION, 2022

FIGURE 13         Global Gabapentin Market: Company Share Analysis, 2022 (%)

FIGURE 14         ZYDUS PHARMACEUTICALS, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15         ZYDUS PHARMACEUTICALS, INC: SWOT ANALYSIS

FIGURE 16         Glenmark Pharmaceuticals Limited: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17         Glenmark Pharmaceuticals Limited: SWOT ANALYSIS

FIGURE 18         SUN PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19         SUN PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS

FIGURE 20         Ascend Laboratories, LLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21         Ascend Laboratories, LLC: SWOT ANALYSIS

FIGURE 22         Apotex Inc..: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23         Apotex Inc..: SWOT ANALYSIS

FIGURE 24         TEVA PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25         TEVA PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS

FIGURE 26         Aurobindo Pharma: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27         Aurobindo Pharma: SWOT ANALYSIS

FIGURE 28         Amneal Pharmaceuticals LLC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29         Amneal Pharmaceuticals LLC.: SWOT ANALYSIS

FIGURE 30         Cipla USA, Inc.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31         Cipla USA, Inc.: SWOT ANALYSIS

Global Gabapentin Market Research Report: Information By Dosage Form (Tablet, Capsule, and Oral Solution), By Type (Generic and Branded), By Application (Epilepsy, Neuropathic Pain, Restless Legs Syndrome, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032.  

Report Code :
RL65112
Published on :
Aug 2023
Request a Free Sample Report


CHOOSE LICENCE TYPE
  • :   $3749   
  • :   $5549   
  • :   $7549   

Latest Reports
Press Release
Get 10% Free Customization
 On This ReportPrint

Print     Speak to Analyst
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your format and defination
  • Gain Deeper Dive on a Specific Application,Geography,Customer or Computer
  • Any Level of Personalization
    •
    Why Choose Us
       

    Our Clients

    electronic and semiconductor      electronic and semiconductor      C2C      electronic and semiconductor      electronic and semiconductor      electronic and semiconductor      SELENIS       electronic and semiconductor            electronic and semiconductor      electronic and semiconductor      electronic and semiconductor      electronic and semiconductor       mips protection       Opulent International       SELENIS       inkuy       MIVV      GSPANN      ANI CO., LTD      C2C      C2C      C2C      C2C      C2C